Fingolimod Bluefish 0,5 mg Kapsel, hård Sverige - svensk - Läkemedelsverket (Medical Products Agency)

fingolimod bluefish 0,5 mg kapsel, hård

bluefish pharmaceuticals ab - fingolimodhydroklorid - kapsel, hård - 0,5 mg - propylenglykol hjälpämne; fingolimodhydroklorid 0,56 mg aktiv substans

Dimethyl fumarate Mylan Den europeiske union - svensk - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetylfumarat - multipel skleros, skovvis förlöpande - immunsuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Neuraxpharm Den europeiske union - svensk - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetylfumarat - multipel skleros, skovvis förlöpande - immunsuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Fingolimod Reddy 0,5 mg Kapsel, hård Sverige - svensk - Läkemedelsverket (Medical Products Agency)

fingolimod reddy 0,5 mg kapsel, hård

reddy holding gmbh - fingolimodhydroklorid - kapsel, hård - 0,5 mg - natriumlaurilsulfat hjälpämne; betadex hjälpämne; fingolimodhydroklorid 0,56 mg aktiv substans

Teriflunomide Mylan Den europeiske union - svensk - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - multipel skleros, skovvis förlöpande - immunsuppressiva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Tecvayli Den europeiske union - svensk - EMA (European Medicines Agency)

tecvayli

janssen-cilag international n.v. - teclistamab - multipelt myelom - antineoplastiska medel - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Fingolimod Pensa 0,5 mg Kapsel, hård Sverige - svensk - Läkemedelsverket (Medical Products Agency)

fingolimod pensa 0,5 mg kapsel, hård

pensa pharma ab - fingolimodhydroklorid - kapsel, hård - 0,5 mg - fingolimodhydroklorid 0,56 mg aktiv substans; propylenglykol hjälpämne

Dimethyl fumarate Teva Den europeiske union - svensk - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Den europeiske union - svensk - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Levodopa/Carbidopa/Entacapone Accord 125 mg/31,25 mg/200 mg Filmdragerad tablett Sverige - svensk - Läkemedelsverket (Medical Products Agency)

levodopa/carbidopa/entacapone accord 125 mg/31,25 mg/200 mg filmdragerad tablett

accord healthcare b.v. - entakapon; karbidopa (monohydrat); levodopa - filmdragerad tablett - 125 mg/31,25 mg/200 mg - levodopa 125 mg aktiv substans; karbidopa (monohydrat) 33,74 mg aktiv substans; entakapon 200 mg aktiv substans